May 24, 2013
IN RE PRADAXA (DABIGATRAN ETEXILATE) PRODUCTS LIABILITY LITIGATION.
Boehringer Ingelheim Pharmaceuticals, Inc., No. 3:12-cv-50009 This Document Relates to: Phyllis Kekich No. 3:12-md-02385-DRH-SCW
DAVID R. HERNDON, District Judge.
Pamela Zarlenga, the Personal Representative of the Estate of Phylis Kekich, deceased, requests leave of court to file a first amended complaint (Doc. 15). The purpose of the amended complaint is to amend the style of the case to reflect the appointment of Pamela Zarlenga, as the Personal Representative of the Estate of Phylis Kekich. Considering the motion the Court ORDERS as follows:
The motion for leave to amend is GRANTED. Movant is DIRECTED to file the amended complaint INSTANTER. FURTHER, upon the filing of the amended complaint, the Clerk of the Court is DIRECTED to revise the docket accordingly.
IT IS SO ORDERED.